11A-4 Molecular Imaging with Targeted Contrast Agents and High Frequency Ultrasound

Targeted ultrasound contrast agents (USCA) can be used as molecular imaging agents to visualize the expression of endothelial molecules (biomarkers). In a murine tumor model, three biomarkers for tumor vasculature were imaged using targeted USCA and the high frequency ultrasound system Vevo 770. Three biomarkers were targeted: VCAM-1, selectins (P and E), and VEGF receptors. Targeting was determined by ultrasound contrast imaging of the adhered USCA in tumors ranging in size from 3 up to 40 mm2. Dependent on the tumor size, targeting of ultrasound contrast agents to the tumor vasculature resulted in significant signal enhancement when compared to control contrast agent. Each targeted contrast agent had it own accumulation level during tumor growth indicating differential expression pattern of the investigated target molecules during tumor growth. High frequency imaging with targeted ultrasound contrast can provide dynamic and quantitative information about the molecular profile of the tumor vasculature. This can open the possibility for patient-tailored therapy and can provide a tool to monitor whether the therapy is having the desired effect.

[1]  Marina V Backer,et al.  Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes , 2007, Nature Medicine.

[2]  M. Rudin.  Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions , 2007, European Radiology.

[3]  Jonathan R Lindner,et al.  Molecular imaging with targeted contrast ultrasound. , 2007, Current opinion in biotechnology.

[4]  P. Lin,et al.  Endothelial cell adhesion molecules and cancer progression. , 2007, Current medicinal chemistry.

[5]  Eric Tom,et al.  Myocardial Ischemic Memory Imaging With Molecular Echocardiography , 2007, Circulation.

[6]  Rolf A. Brekken,et al.  Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature , 2007, Clinical Cancer Research.

[7]  M. Descour,et al.  Molecular optical imaging of therapeutic targets of cancer. , 2006, Advances in cancer research.

[8]  S. Acton,et al.  Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. , 2006, Contrast media & molecular imaging.

[9]  William R Wagner,et al.  Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. , 2005, Cancer research.

[10]  Klaus Ley,et al.  Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[11]  P. Kubes,et al.  Lipopolysaccharide-Induced Leukocyte-Endothelial Cell Interactions: A Role for CD14 Versus Toll-Like Receptor 4 Within Microvessels1 , 2002, The Journal of Immunology.

[12]  R. Brekken,et al.  VEGF-VEGF receptor complexes as markers of tumor vascular endothelium. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[13]  S. Tsuboi,et al.  Acquisition of P-selectin binding activity by en bloc transfer of sulfo Le(x) trisaccharide to the cell surface: comparison to a sialyl Le(x) tetrasaccharide transferred on the cell surface. , 2000, Archives of biochemistry and biophysics.

[14]  Christine H Chung,et al.  Genomics and proteomics: emerging technologies in clinical cancer research. , 2007, Critical reviews in oncology/hematology.